MoneyWorks4Me

Hemant Surgical Industries Ltd (543916)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543916 NSE: Medical Equipment/Supplies/Accessories | Small Cap | Hemant Surgical Inds Share Price

₹573 75.00 (15.06%)

As on 22-Sep'26 13:09

Hemant Surgical Industries Ltd (543916)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543916 NSE: Medical Equipment/Supplies/Accessories | Small Cap | Hemant Surgical Inds Share Price

₹573 75.00 (15.06%)

As on 22-Sep'26 13:09

Key Metrics
Valuation Multiples
Market Cap
₹724 Cr.
Current Price
₹573
52-Week Low / High
₹215 / 498
TTM EPS
₹12.5
TTM Sales
₹232 Cr.
Book Value per Share
₹99
P/E Ratio
39.80
Higher than its 5-year historical median
Industry PE
127.5
Price to Book (P/B)
5.03
Higher than its 5-year historical median
Price to Sales (P/S)
3.12
Higher than its 5-year historical median
EV/EBITDA
25.63
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
12.73%
Outperforms industry median
Return on Capital Employed (ROCE)
13.58%
Outperforms industry median
Return on Assets (ROA)
5.43%
Operating Profit Margin
9.6%
Net Profit Margin
7.54%
Gross Profit Margin
11.2%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
0.87%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
58.90%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹129 Cr.
Equity
₹14.5 Cr.
Face Value
₹10
All Time Low / High
₹88.15 / 497.00

Hemant Surgical Industries stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Overvalued

Price Trend

Weak
Q.1 Is Hemant Surgical Industries Ltd a good quality company?
Hemant Surgical Industries Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Hemant Surgical Industries Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Hemant Surgical Industries Ltd vs industry peers?
Hemant Surgical Industries Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Q.1 Promoter shareholding and pledge status of Hemant Surgical Industries Ltd?
Promoters hold 58.90% of the Hemant Surgical Industries Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Hemant Surgical Industries Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of 41.62% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Hemant Surgical Industries Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 15.7%14.8%14.5%15.2%11.6%14.3%32.9%45.2%29.9%16.6%-
Value Creation
Index
0.10.10.00.1-0.20.01.42.21.10.2-

Growth Parameters

Sales 39.651.550.655.756.159.8104109106107231
Sales YoY Gr.-30%-1.8%10.1%0.8%6.5%73.3%5.4%-3.2%0.9%-
Adj EPS 2.62.82.93.52.73.610.68.67.86.512.5
YoY Gr.-6.1%5.8%20.8%-24.3%33.6%195.5%-18.5%-9.1%-17.4%-
BVPS (₹) 20.420.22123.725.126.741.130.452.660.398.9
Adj Net
Profit
0.60.80.91.10.91.13.46.68.26.818
Cash Flow from Ops. 00000-0.312.16.3-4.28.9-
Debt/CF from Ops. 00000-53.40.81.1-1.63.5-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 11.6%13.7%0.9%0.9%
Adj EPS 10.6%19.3%-15.1%-17.4%
BVPS12.8%19.2%13.7%14.8%
Share Price - - 42.3% 62.5%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
13.314.91515.81112.929.536.320.911.515.8
Op. Profit
Mgn %
5.94.74.94.84.65.96.19.79.99.7NAN
Net Profit
Mgn %
1.61.61.921.51.93.36.17.86.47.9
Debt to
Equity
2.31.91.31.51.81.70.70.30.10.5-
Working Cap
Days
2161501401421681711141321852550
Cash Conv.
Cycle
53321451830201735770

Valuation of Hemant Surgical Inds - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'25
Sales107
Operating Expenses + 98
Manufacturing Costs2
Material Costs76
Employee Cost 7
Other Costs 12
Operating Profit 9
Operating Profit Margin (%) 8.5%
Other Income + 5
Exceptional Items 0
Interest 2
Depreciation 1
Profit Before Tax 10
Tax 2
Profit After Tax 8
PAT Margin (%) 7.5%
Adjusted EPS (₹)7.7
Dividend Payout Ratio (%)0%
PARTICULARSMar'25

Equity and Liabilities

Shareholders Fund + 63
Share Capital 10
Reserves 53
Debt +27
Long Term Debt23
Short Term Debt3
Minority Interest0
Trade Payables39
Others Liabilities 19
Total Liabilities 148

Fixed Assets

Net Fixed Assets +40
Gross Block47
Accumulated Depreciation7
CWIP 12
Investments 1
Inventories43
Trade Receivables20
Cash Equivalents 10
Others Assets 22
Total Assets 148
PARTICULARSMar'25
Cash Flow From Operating Activity + 9
PBT 10
Adjustment 4
Changes in Working Capital -4
Tax Paid -2
Cash Flow From Investing Activity + -30
Capex -36
Net Investments 3
Others 3
Cash Flow From Financing Activity + 18
Net Proceeds from Shares 0
Net Proceeds from Borrowing 20
Interest Paid -2
Dividend Paid 0
Others 0
Net Cash Flow -4
PARTICULARSMar'25
Ratios
ROE (%)12.73
ROCE (%)13.58
Asset Turnover Ratio0.72
PAT to CFO Conversion(x)1.13
Working Capital Days
Receivable Days69.80
Inventory Days147.70
Payable Days188

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hemant Surgical Industries Ltd FAQs

The current trading price of Hemant Surgical Inds on 22-Sep-2026 13:09 is ₹573.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Sep-2026 the market cap of Hemant Surgical Inds stood at ₹724.0 Cr

The latest P/E ratio of Hemant Surgical Inds as of 21-Sep-2026 is 39.70.

The latest P/B ratio of Hemant Surgical Inds as of 21-Sep-2026 is 5.04.

The 52-week high of Hemant Surgical Inds is ₹498.0 and the 52-week low is ₹215.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Hemant Surgical Inds is ₹231 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Hemant Surgical Industries Ltd is a below average quality company.

The key valuation ratios of Hemant Surgical Industries Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Hemant Surgical Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Hemant Surgical Industries Ltd

The company was originally incorporated as ‘Hemant Surgical Industries Private Limited’ under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated March 27, 1989, by Registrar of Companies, Maharashtra, Mumbai. Subsequently the company was converted into a public limited company vide special resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 24, 1994 and the name of the company was changed from ‘Hemant Surgical Industries Private Limited’ to ‘Hemant Surgical Industries Limited’ vide fresh Certificate of Incorporation granted to the company consequent upon conversion into public limited company dated February 22, 1994 by the Registrar of Companies, Maharashtra, Mumbai.

The company manufactures, import, assemble and market a comprehensive portfolio of medical equipments and disposables. Its product offerings cover a wide spectrum of equipments and disposables required for (i) Renal Care, (ii) cardiovascular disease (iii) respiratory disease, (iv) Critical Care and Radiology and (v) Surgical disposables. Its wide range of products includes some of the indigenously manufactured products along with some other products that are imported from countries like: Japan, China France and Australia and are further processed in its assembly units. In addition it is also providing services for maintenance and running of dialysis centres.

The company started its operations with importing and marketing of medical disposables like: meditapes, all over India from JMS Company Japan. Later in the year 1999 the company started its manufacturing operations with one Manufacturing unit and over the years expanded its manufacturing and assembly operations to two more additional units. Its facilities are ISO 9001:2015 and ISO 13485:2016 certified having fully equipped quality control department with experienced and qualified staff to facilitate smooth manufacturing and assembly line process. The company was founded in the year 1989 by one of its Promoters, Hanskumar Shamji Shah, who has over 35 years of experience in the industry.

Business of the company 

Hemant surgical Industries is engaged in the business of manufacturing, importing, assembly and marketing of medical equipments and disposables.

Products of the company

Healthcare products and medical equipments

  • Hemodialysis machine
  • Dialysis Solution - Acidic and bicarbonate
  • Dialyzer
  • ECG machine
  • ECG electrode
  • Nebulizer
  • Paramonitors
  • Ultrasound machine
  • Ventilator

Surgical disposables

  • Meditape
  • Intravenous infusion set
  • Scalp vein set
  • Foley catheter
  • 3 Ply masks

Other healthcare products

  • Digital thermometer
  • Cold and hot sterilant
  • Fully automatic comfort dialysis chair
  • Five-Function electric ICU bed with mattress

History and milestones

  • 1989: Incorporation of the company in the name of ‘Hemant Surgical Private Limted’.
  • 1993: Became the Sole Agent for JMS Co. Ltd, Japan, for JMS, Meditape.
  • 1994: Conversion into Public Limited company with the name Hemant Surgical Industries Ltd. 
  • 1999: Started its first manufacturing plant at Achhad, Maharashtra for External Preparation and Small Volume Parentals.
  • 2018: Entered into exclusive distribution agreement dated July 01, 2018, valid for a period of 6 years, with JMS Co. Ltd., Japan for importing and marketing JMS Meditape in India. The imported meditape undergoes the process of rewinding, slitting, and packaging in its assembly unit situated at Atgaon and is then sold in Indian market.
  • 2019: Entered into technical collaboration agreement with JMS Singapore Pte. Ltd. for manufacturing Intravenous Infusion Set which are sold under the brand name ‘JMS’ in India.
  • 2019: Signed exclusive distribution agreement with Hemant Phillipines Inc./ Mediply Inc. for supply of renal care equipment, medical devices and consumables for marketing the same in entire Phillipines.
  • 2021: Appointed as sole agent of SWS Hemodialysis Care Co. Ltd., Chinato sell and do maintenance of SWS4000A hemodialysis machines in West India on exclusive basis.
  • 2021: Entered into MOU with Dr. Venkatesh for setting up of dialysis centre at Guru Harikrishan Hospital 24x7 Dialysis Centre, New Delhi. 
  • 2022: Achieved a Bench mark of 100 Cr Turnover in the FY 2021-22.

You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now